Navigation Links
Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008
Date:5/8/2008

IRVINE, Calif., May 8 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced that the company will celebrate a number of cardiac surgery milestones and product debuts at the 88th annual meeting of the American Association for Thoracic Surgery (AATS), May 10-14 in San Diego.

Among the milestones marked by Edwards -- which this year celebrates its 50th anniversary of partnering with clinicians to develop life-saving innovations -- are:

-- The treatment of more than 1 million patients worldwide with Edwards'

heart valve repair and replacement technologies.

-- The implantation of the Edwards SAPIEN transcatheter aortic heart valve

in more than 1,000 patients worldwide through a series of extensive

clinical trials and feasibility studies in Europe, the U.S. and Canada,

as well as commercial sales in Europe.

-- The start of patient enrollment for transcatheter aortic valve

replacement procedures with the Ascendra transapical delivery system at

participating sites in Edwards' U.S. pivotal trial of the Edwards

SAPIEN valve. Edwards has conditional approval from the U.S. Food and

Drug Administration to perform procedures with both the Ascendra

transapical delivery system and the RetroFlex transfemoral delivery

system at the PARTNER trial sites.

-- Regulatory and reimbursement approval received this week from the

Japanese Ministry of Health for the Carpentier-Edwards PERIMOUNT Magna

pericardial aortic heart valve. As the first and only device of its

kind, this valve combines more than 20 years of clinical experience and
'/>"/>

SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
2. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
3. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
6. Edwards Lifesciences Forecasts Strong Growth in 2008
7. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
8. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
9. Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
10. Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. Edwards Lifesciences Announces Organizational Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 2013 was a ... Brain State Technologies®. They saw continued independent research led ... who were awarded a $1 million grant from the ... “Brain and Behavior” a peer reviewed journal, Amy Grant ...
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
(Date:1/14/2014)... 14, 2014 Histogen, Inc., a regenerative ... cells grown under simulated embryonic conditions, today announced that ... Suneva Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s ... This agreement is an amendment to the existing license ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 EquitiesIQ, a ... Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical company ... the wound care market. , Free report download: ... with a seasoned management team and Board, which launched ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Calif., Feb. 29 Kosan Biosciences,Incorporated (Nasdaq: ... Kosan,s,Senior Vice President and Chief Financial Officer, will ... Healthcare Conference in,New York at the W Hotel ... EST. A live,webcast of the presentation can be ...
... MannKind,Corporation (Nasdaq: MNKD ) will release its ... at 7:00 a.m. ET., Management of the Company ... financial results, clinical progress and other Company,developments at 9:00 ... the,Company will be its Chairman and Chief Executive Officer, ...
... DEERFIELD, Ill., Feb. 28 Baxter International,Inc. announced ... voluntary,recall of all remaining lots and doses of ... heparin flush products., The company initially recalled ... January 17, 2008 as a precautionary measure due ...
Cached Biology Technology:Kosan Biosciences to Present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference 2MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008 2Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products 2Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products 3
(Date:4/17/2014)... peppers. Information about archaeological remains of ancient chili peppers ... of words for chili peppers in ancient dialects helped ... the value of multi-proxy data analysis. Their results are ... presented in a special feature issue of the ... plant and animal domestication edited by Dolores Piperno, staff ...
(Date:4/17/2014)... NJ. April 16, 2014. Kessler Foundation has been ... million from the Department of Defense Spinal Cord ... principal investigator for the randomized, double-blinded, controlled, multi-site ... bone and muscle strength after spinal cord injury. ... & Engineering Research at Kessler Foundation. Two additional ...
(Date:4/17/2014)... Luca Razzari of the nergie Matriaux Tlcommunications Research ... the John R. Evans Leaders Fund of the ... of state-of-the-art biotech and nanophotonics equipment. To this ... Ministre de l,Enseignement suprieur, de la Recherche, de ... new laboratories will help us develop new approaches ...
Breaking Biology News(10 mins):Chickens to chili peppers 2Chickens to chili peppers 3Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2New state-of-the-art biotech and nanotech equipment for INRS 2
... few extra treats this holiday season? Soon, your cell ... exercise routine and keep the pounds off over winter ... keep track. Researchers at the University of Washington ... dubbed UbiFit and UbiGreen, to automatically track workouts and ...
... PITTSBURGHTwo groups of researchers at Carnegie Mellon University,s Robotics ... grants from the U.S. Department of Agriculture (USDA) to ... and one is for orange growers, but both are ... The systems use sensors on autonomous robotic vehicles ...
... new compounds created by a University of Central Florida ... Associate Professor James Turkson,s compounds disrupt the formation ... mice. The compounds, S3I-201 and S3I-M2001, break up ... no negative side effects so far. "The compounds ...
Cached Biology News:Track your fitness, environmental impact with new cell phone applications 2Track your fitness, environmental impact with new cell phone applications 3Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 2Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 32 new compounds show promise for eliminating breast cancer tumors 2
...
... Antibody Modification Services ,,GenScript ... antibody labeling and antibody fragmentation. Labeling ... signals for visualization and quantitation of ... it is preferable to use only ...
Attoglow Western Blot Enhancing Kit contains Millennium Enhancer which can significantly boost Western blot signals, and is compatible with other enhancing mechanisms to achieve multiplied enhancing ...
Immunogen: Synthetic peptide: S(399) P W S E L E F Q F P D D K D P V W E F(418) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: